Suscribirse

Lung alveolar regeneration by p16 deletion in alveolar epithelial cells - 17/02/23

Doi : 10.1016/j.rmr.2022.11.012 
B. Ribeiro Baptista 1, , J. Grégoire 1, M. Toigo 1, M. Zysman 1, C. Thibault de Menonville 1, R. Belgacemi 1, F. Chabot 2, S. Adnot 1, 3, G. Derumeaux 1, 3, J. Boczkowski 1, L. Boyer 1, 3
1 Institut Mondor de recherche biomédicale, Inserm, université Paris Est Créteil 
2 Département de pneumologie, CHRU Nancy 
3 AP–HP, hôpital Henri-Mondor, physiologie, Créteil 

Corresponding author.

Resumen

Introduction

Alveolar regeneration involves dynamic changes of a major progenitor cell in alveoli, alveolar type 2 cells (AT2) that may be altered in alveolar diseases such as emphysema. Targeting p16, a cell cycle inhibitor involved in stem cell fate, in AT2 could be a way to restore AT2 plasticity and promote alveolar regeneration.

Methods

In vivo, morphological analysis (mean linear intercept), AT2 (pro-SpC) number and KRT8+ cells were quantified in wild type (WT) or p16-/- mice at D21, D90 and D150 after elastase (lung destruction) or PBS instillation. In vitro alveolar organoids were used to test the regenerative properties of EpCAM+ cells (from p16-/- or WT mice lung). Number and size of organoids were quantified at D14 of culture. bgalactosidase staining was used to quantified senescence. Senolytics (Dasatinib+Quercetin) were used in vitro on organoids and in vivo between D21 and D90 (5/7days) after elastase instillation. Single cell RNAsequencing was used to determine EpCAM+ cells associated with a regenerative process in the lung and organoids.

Results

In vivo, p16 was overexpressed in AT2 of WT mice with a lung destruction compared to control. Deletion of p16 was not protective for alveolar architecture at D21 in the elastase model, but p16-/- mice had less alveolar destruction than WT mice at D90 and D150, highlighting a regeneration process occurring after D21. At D21, p16 deletion in elastase mice was associated with an increase in number of AT2, increase of pro-SPC+KRT8+ cells and decrease of senescence. Organoids made with epithelial cells from injured lung of WT mice were fewer and smaller than PBS injected mice. Number and size of organoids made with lung epithelial p16-/- elastase mice cells were more numerous and bigger than organoids made with EpCAM+ WT elastase mice. Supplementation of organoids medium with senolytics decrease bgalactosidase staining of organoids and increase the number and size of organoids. Senolytics in vivo demonstrate a regenerative alveoli process occurring in a curative manner between D21 and D90. Single cell analysis showed an increase, exclusively in p16-/- emphysematous lung, of a specific cluster of AT2 cells expressing KRT8 that need to be described more precisely.

Conclusions

Targeting p16 may reverse alveolar epithelial cell dysfunction and increases endogenous alveolar regeneration by increase a new subpopulation of AT2 characterized by KRT8+ markers and associated with p16possenescent cells elimination.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2022  Publicado por Elsevier Masson SAS.
Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 40 - N° 2

P. 114 - février 2023 Regresar al número
Artículo precedente Artículo precedente
  • Défaut de mobilisation par l’exercice des cellules souches/progénitrices endothéliales chez les patients BPCO et réponse vasculaire à la réhabilitation respiratoire
  • E. Desplanche, L. Blervaque, S. Günther, M. Gruest, A. Philippe, J. Rancic, N. Gendron, C. Hédon, N. Heraud, A. Perez-Martin, A. Virsolvy, O. Cazorla, G. Condurache, N. Plouvier, A. Proust, Y. Dauvilliers, M. Hayot, E. Rossi, A. Bourdin, F. Gouzi, D. Smadja
| Artículo siguiente Artículo siguiente
  • A high probability of short-range interactions between fibrocytes and CD8+ T cells potentiates the inflammatory response in COPD
  • E. Eyraud, E. Maurat, J.-M. Sac-Epée, P. Henrot, M. Zysman, R. Prevel, P. Esteves, T. Trian, H. Bégueret, P.O. Girodet, M. Thumerel, R. Hustache-Castaing, R. Marthan, F. Levet, J.-B. Sabarita, P. Vallois, C. Contin-Bordes, P. Berger, I. Dupin

¿Ya suscrito a @@106933@@ revista ?